Drug designed to treat metastatic pancreatic cancer may help extend life

by Stony Brook UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA drug developed by researchers at the Renaissance School of Me

Updated on: May 09,2024

Drug designed to treat metastatic pancreatic cancer may help extend life

by Stony Brook UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA drug developed by researchers at the Renaissance School of Me

Updated on:May 09,2024

Blocking key pathways is a way to defeat cancer stem cells

by RIKENCancer cell during cell division. Credit: National Institutes of HealthScientists from the RIKEN Center for Integrative Medical Sciences in Japan and international collaborators have foun

Updated on: April 01,2024

Blocking key pathways is a way to defeat cancer stem cells

by RIKENCancer cell during cell division. Credit: National Institutes of HealthScientists from the RIKEN Center for Integrative Medical Sciences in Japan and international collaborators have foun

Updated on:April 01,2024

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on: January 11,2024

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on:January 11,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on: January 22,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on:January 22,2024

Researchers identify effective drug combination against uveal melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Uveal mela

Updated on: June 08,2024

Researchers identify effective drug combination against uveal melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Uveal mela

Updated on:June 08,2024

Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on: August 27,2024

Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on:August 27,2024

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on: May 27,2024

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on:May 27,2024

Solving the mystery of NPM1 in acute myeloid leukemia

by Allison Mickey,Baylor College of MedicineDr. Margaret Goodell, the corresponding author of this work. Credit: Baylor College of MedicineAlthough it has long been recognized that mutations of

Updated on: March 12,2024

Solving the mystery of NPM1 in acute myeloid leukemia

by Allison Mickey,Baylor College of MedicineDr. Margaret Goodell, the corresponding author of this work. Credit: Baylor College of MedicineAlthough it has long been recognized that mutations of

Updated on:March 12,2024

Genetic ancestry and social environment may influence how aggressive breast cancer is in Black women

by Rutgers Cancer Institute of New JerseyKaplan-Meier Survival Curves for All-Cause Mortality by Quartiles (Q) of African Ancestry and Neighborhood Socioeconomic Status (nSES) in 1,575 Black Women wit

Updated on: May 13,2024

Genetic ancestry and social environment may influence how aggressive breast cancer is in Black women

by Rutgers Cancer Institute of New JerseyKaplan-Meier Survival Curves for All-Cause Mortality by Quartiles (Q) of African Ancestry and Neighborhood Socioeconomic Status (nSES) in 1,575 Black Women wit

Updated on:May 13,2024

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on: March 30,2024

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on:March 30,2024

New study shows immigrant adults with liver cancer have higher survival rates than those born in the US

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainImmigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in

Updated on: February 01,2024

New study shows immigrant adults with liver cancer have higher survival rates than those born in the US

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainImmigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in

Updated on:February 01,2024

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on: March 08,2024

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on:March 08,2024